Background: Poorly or partially treated wastewater disposed of can contaminate water and even properly treated sewage can have its problems. The highlight of this danger is wastewater treatment plants serving as reservoir for proliferation of antibiotic resistant organisms. We have reported the state of two wastewater treatment in the Eastern Cape of South Africa which discharge poorly and partially treated effluents. Our aims to identify Vibrio spp. and their antibiotic profiles in treated final effluent discharge from wastewater treatment plant.
INTRODUCTION
Vibrio are gram negative, rods and are motile with a polar flagellum containing diverse groups [1, 2] . Members of various species are known to cause acute gastroenteritis infections [3, 4] , wound infections and primary septicemia [5] . Many Vibrio spp. are pathogenic to humans and have been implicated in food-borne disease [6] . They are naturally found in the estuarine and marine environment [7, 8] . The aquatic environment have been identified to be a medium of transmission of this organism through which the isolation of the organism has been found in seafood [7, 9, 10] . The isolation of the microorganism from raw sewerage as well as the final treated effluent showed that wastewater treatment plants do not remove or inactivate all pathogenic microorganisms [11, 12] and hence Wastewater has been implicated in the distribution of Vibrio in the environment and surface water [13, 14] . Study have shown the presence of high level antibiotic resistance Vibrio cholerae in the final effluent of stabilization pond revealing the imminent danger of poorly treated effluent [15] . One of the recent deadliest outbreaks of the organism was in Haiti which was attributed to poor wastewater management and the existence of poor sanitary condition in the country [16, 17] . South Sudan and Kenya are recently ravaged by cholera outbreak, and the world worst's outbreak is in Yemen [18] [19] [20] [21] . In South Africa, Vibrio has been isolated from faeces of domestic animals in rural area of Limpopo [22] and in 2002, the province recorded one of its first outbreak of the diseases [23, 24] . Between 2002 and 2004 , there have been reported cases of the disease outbreak in the Eastern Cape of South Africa [25] . More studies from the region found Vibrio spp. isolated from treated effluents of wastewater treatment plants [12, 26] .
Worldwide, cases of most bacterial pathogens becoming more resistant to commonly used antimicrobial agents are increasing [27] . In developing countries, increase in antimicrobial resistance in enteric pathogens is especially important where diarrhea is common [28] . Multi drug resistance has been reported in effluent from Wastewater treatment in Eastern Cape, which are considered reservoir for antibiotic resistance bacteria [29, 30] . Effluent water is still daily discharged into surface water in the Eastern Cape and therefore the essence of this monitoring study is on the antibiotic resistance prevalence of the organism in the final effluent of wastewater treatment plant. This formed part of a large project study done and reported [31] [32] [33] . This study build upon the state of knowledge on effluent quality discharge in the Eastern Cape. This study profile approach centered on antimicrobial agents for use in treatment of cholera as recommended by the WHO.
MATERIALS AND METHODS
The detailed sampling sites for 2 wastewater treatment plants WWTP-A and WWTP-B, sampling collection and processing is as reported and published in Osuolale & Okoh, [32] .
Isolation of Vibrio
Enumerations of presumptive Vibrio pathogens were carried out by the method using sterile TCBS agar plants as described by Bopp et al., [34] . Bacteriological analysis of the effluent samples for bacteria counts and isolation was determined by membrane filtration (47mm, 0.45mm pore size), according to SABS, [35] . Serial dilutions of the samples were prepared. Sample dilutions were homogenate before filtering (100ml). On certain occasions where there was excessive chlorine dosage in the effluent, the raw samples were filtered. The filtered samples were placed on selective agar for the target organisms in triplicates. The plates were allowed 15 minutes to dry, invert, and incubate promptly for 24hrs at 37 °C. After 48 hours incubation, colonies appearing as greenish or yellowish in colour were counted and reported as CFU/100 ml SABS, [35] in suitable range (0-300 colonies). Presumptive Vibrio bacteria isolated from the plates were purified and subjected to molecular identification. Polymerase chain reaction (PCR) was used to confirm the identities of the Vibrio species using the species specific primers as described by Tarr et al., [1] . 
Antimicrobial susceptibility
The antibiotic susceptibility testing for Vibrio isolates was determined using the following antibiotic discs: ampicillin (10 µg), tetracycline (30 µg), chloramphenicol (30 µg), cefotaxime (30 µg), Trimethoprim-sulfamethoxazole (1.25/23.75 µg), and ciprofloxacin (5 µg). The choice of antibiotics was based on recommended drug for primary testing of Vibrio spp. by CLSI [40, 41] . minimal level, is of concern judging from the nature of the organism as one having the potential to initiate epidemic infection.
The samples positive for Vibrio spp. were further screened for the V. parahaemolyticus, V. vulnificus and V. fluvialis pathotypes. All the screened isolates were negative for the tested Vibrio pathotypes. The target genes (Table 1 ) specific for the identification of these pathotypes were not detected in the tested isolates. With the exception of V. cholera which could not be tested the tested strains are not ubiquitous to the natural fresh or salt aquatic environment as are the V. cholera [11] . V. fluvialis, V. parahaemolyticus and V. vulnificus are reported as the most frequently encountered pathogenic Vibrios in marine environments, coastal, estuaries and brackish waters as well as seafood, which is considered a natural habitat for this strains of Vibrio spp. [4, 56] . In contrast to our work is the study done by Igbinosa, [12] who reported the presence of the V. fluvialis, V. parahaemolyticus and V. vulnificus in the final effluent of a wastewater treatment plant. The prevalence of these pathogenic Vibrio in the environment were reported to be influenced by temperature and salinity and the concentration of salinity differs for each Vibrio spp. at which they can survive [5, 9] . The public health consequences of these pathogenic organisms cannot be over emphasized as all these strains have been attributed to human diseases [1] and are known to cause gastrointestinal disease syndrome [57] .
Antimicrobial susceptibility testing for Vibrio spp. Vibrio spp. are considered to be significant infectious pathogens which are the causative agents for vibrosis [58, 59] . They are characterized by diarrhea, wound infections, primary septicemia, and gastroenteritis or other extra-intestinal infections related to exposure to contaminated sources [60] . Most isolates tested in this study were susceptible to the antimicrobial agents recommended for primary testing by CLSI [40] . Treatment recommendations for Vibrio infections include: tetracycline (doxycycline, tetracycline), fluoroquinolones (ciprofloxacin, levofloxacin), third-generation cephalosporins (cefotaxime, ceftazidime, ceftriaxone), aminoglycosides (amikacin, apramycin, gentamicin, streptomycin) and folate pathway inhibitors (trimethoprim-sulfamethoxazole) [61, 62] . All Vibrio spp. studied here showed some degree of resistance to all the antibiotics used for testing. In the present study, data on antibiotic resistant zones indicate that all the 100 isolates of Vibrio spp. were 38% resistant to tetracycline, 26% to ampicillin, 16% to chloramphenicol, 14% to cefotaxime, 13% to trimethoprim-sulfamethoxazole and 1% to ciprofloxacin.
The result of antimicrobial susceptibility testing showed Vibrio isolates had the highest susceptibility of 92% to ciprofloxacin. Similar susceptibility level to ciprofloxacin was reported by Ismail et al., [63] during a study of Vibrio cholera outbreak in South Africa. About 90% of Vibrio isolated from river water used as water sources in a rural communities of Venda in South Africa were susceptible to ciprofloxacin [64] . Igbinosa, [12] worked on Vibrio spp. isolated from the final effluent of a wastewater treatment plant in South Africa reported susceptibility in the range of 70% to 90% to the antibiotics. Report from other studied areas show similar susceptibility level at 100% susceptible [62, [65] [66] [67] ] as compared to the 92% recorded in this study while 96.4% susceptibility was reported by Benedicta, [68] . Other Vibrio spp. which is mostly associated sea animals and marine environments are also reported to be susceptible to the antibiotic [69] . Reduced susceptible has been reported in two West Africa countries [70, 71] , India [72] and Bangladesh [73] showing the possibility of the organism to develop resistance. It was highlighted in the Leclercq et al., [74] , when antibiogram with quinolones are read, resistance to the most active fluoroquinolone in vitro indicates resistance to all fluoroquinolones in both Gram-negative and Gram-positive organisms An exception to this rule in Gram-negative organisms is the potential production of the AAC(6')-Ib-cr enzyme, which affects ciprofloxacin but not levofloxacin [74] . Kim et al., [75] were able to demonstrate the transferrable of quinolone resistance gene in Vibrio cholera and thus highlights the opportunities for gene exchange among bacteria living in aquatic environments which can confer resistance.
Trimethoprim-sulfamethoxazole or co-trimoxazole has an appreciable level of susceptibility of about 80%. Report by Shaw et al., [62] showed full susceptibility to trimethoprim-sulfamethoxazole. This is however in sharp contrast to the susceptibility of Vibrio to the antibiotic previously reported where high level of resistance has been documented for Vibrio isolates from South Africa [63, 76, 77] , India [72, 78] and the Vietnam [67] . Likewise multiple resistances has been reported for antibiotics tested along with co-trimoxazole which include ampicillin [72, 77, 79] . This as well corroborate with the work done by Igbinosa, [12] who reported ampicillin resistance to Vibrio spp. isolated from the final effluent at the Eastern Cape, South Africa. This study recorded 58% susceptibility level with 29% resistance to ampicillin. This compared favorably with other studies which exhibiting resistance to ampicillin [61, 80, 81] [63] was conversely quick to point out the observed change to the susceptibility of some of the same isolate tested on ampicillin to have suddenly become resistance though at a very minimal resistance level, further showing the rapid development antibiotics resistance of Vibrio cholera in South Africa. In addition, the CLSI publication stated result for ampicillin can be used to predict for amoxicillin [82] . It can therefore be deduced that amoxicillin will as well have variant susceptibility or resistance to Vibrio spp. Susceptibilities of Vibrio spp. have been shown to vary by species, particularly with regard to the older penicillin, cephalosporins, and sulfonamides [83] .
In contrast to our study, we had an susceptibility of 54% to tetracycline while [71] reported high susceptibility to the antibiotic. There were others who reported intermediate resistant to tetracycline [67] , and co-multiple resistances to tetracycline and chloramphenicol [76] [77] [78] [79] . According to the CLSI documentation, Organisms susceptible to Tetracycline are also considered susceptible to doxycycline and minocycline. However, some organisms that are intermediate or resistance to tetracycline may be susceptible to doxycycline or minocycline or both [82] . Tran et al., [67] are able to show in their work susceptibility to doxycycline by Vibrio cholerae with intermediate resistance.
The observed susceptibility level for chloramphenicol was 64% as against 100% susceptibility recorded from other others [63, 67, 71] and Igbinosa, [12] reported 100% resistance to the chloramphenicol. Vibrio spp. across different studies showed variants levels of susceptibility to resistance to chloramphenicol [84, 85] Wastewater treatment plant becoming source of antibiotic reservoir for bacteria is a concern. The increasing threat posed by them stem from mismanagement of the treatment processes. Treated effluent studied by Larsson, de Pedro, & Paxeus, [92] found that effluent does constitute major environmental problem as a result pharmaceutical products from industrial wastes. Li et al., [93] report the presence of Penicillin G and its degraded products in effluent sample analysed. The presence of Fluoroquinolones and sulfamethoxazole have also been detected in the effluent of some wastewater plants in the western cape of South Africa [94] . However it is yet to be agreed upon if wastewater treatments plants is an important source in the emergence of resistant bacteria in the environment, i.e. is the concentration of the antibiotic and the bacterial density high enough, is the exposure long enough to promote resistance or to select resistant bacteria [95] . Though it has been shown that Bacteria can acquire multidrug resistance through sequential transfer of multiple-resistance determinants located on mobile genetic elements [96] their ability to do so in wastewater treatment plants are yet to be fully established [95] . Though recent report by Luo et al., [97] confirmed the possibility of gene transfer from resistant organism to indigenous organisms in wastewater treatment plant. Ohlsen et al., [98] indicate that the transfer of resistance and the selection of resistant bacteria are not favored at antibiotic concentrations as high as those found in hospital effluents or the aquatic environment. Most resistance organisms found in the environment are believed to have come from previously resistant organism. In the review work of Kümmerer, [95] showed that resistant organisms were both isolated from effluents which received hospital waste and municipal influent. This debunks the view that resistant organisms would have been more prevalent in plant receiving hospital waste as compared to municipal plant. Some of the resistant isolates observed in this study could as well as arise from the surrounding communities since there is no source of pharmaceutical industrial influents or hospital waste into the plants. The fallback will be on the use of antibiotic within the communities as this has been reported as source of antibiotics in the environment [99] and the occurrence of antibiotics may promote the selection of antibiotic resistance genes (ARGs) and antibiotic resistant bacteria (ARB), which pose health risks to the environment, humans and animals [100] . Dalsgaard et al., [76] demonstrated multiple-drug resistant V. cholerae o1 isolates showing resistance to all the antibiotics traditionally used to treat cholera which is disturbing and has a direct impact on the treatment of current and future cholera cases in South Africa and other countries to which this isolate may spread.
Therefore, continued monitoring of both the prevalence and the antimicrobial susceptibility profile is important to better ensure environmental safety; particularly single resistance to ciprofloxacin observed against Vibrio also limit treatment effectiveness and should be monitored. As most of the antimicrobial agents recommended for treatment of E. coli and Vibrio illnesses by CLSI showed some form of resistances is likely to be problematic. Based on our data, treatment of illnesses may benefit from the use of meropenem that was 100% effective against E. coli and ciprofloxacin which was the only antibiotics that was 99% effective against Vibrio spp. in this study.
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